Hartkoorn, R. C., San Kwan, W., Shallcross, V., Chaikan, A., Liptrott, N., Egan, D., . . . Owen, A. (2010). HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms. Pharmacogenet Genomics.
Citação norma ChicagoHartkoorn, Ruben C., et al. "HIV Protease Inhibitors Are Substrates for OATP1A2, OATP1B1 and OATP1B3 and Lopinavir Plasma Concentrations Are Influenced By SLCO1B1 Polymorphisms." Pharmacogenet Genomics 2010.
MLA引文Hartkoorn, Ruben C., et al. "HIV Protease Inhibitors Are Substrates for OATP1A2, OATP1B1 and OATP1B3 and Lopinavir Plasma Concentrations Are Influenced By SLCO1B1 Polymorphisms." Pharmacogenet Genomics 2010.
警告：這些引文格式不一定是100％准確.